N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine

CAS: 231277-92-2

Ref. AN-AG0039KT

Información del producto

• Nombre: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine
• Sinónimos: [u'GW 282974X', u'GW 572016', u'GW-282974X', u'GW-572016', u'GW282974X', u'GW572016', u'lapatinib', u'lapatinib ditosylate', u'N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl) -2-furyl)-4-quinazolinamine', u'Tykerb', u'Lapatinib', u'231277-92-2', u'Tykerb', u'GW572016', u'GW 572016', u'Lapatinib base', u'Lapatinib tosilate hydrate', u'Lapatinib [INN]', u'Tyverb', u'388082-78-8', u'Lapatinib (INN)', u'Lapatinib free base', u'GSK 572016', u'UNII-0VUA21238F', u'GSK572016', u'MFCD09264194', u'FMM', u'N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE', u'CHEMBL554', u'CHEBI:49603', u'0VUA21238F', u'NSC745750', u'GW-572016', u'NCGC00167507-01', u'C29H26ClFN4O4S', u'DSSTox_CID_26675', u'DSSTox_RID_81812', u'DSSTox_GSID_46675', u'N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine', u'N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine', u'Q-101353', u'Tycerb', u'4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-', u'4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-', u'N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine', u'N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine', u'N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine', u'N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine', u'CAS-231277-92-2', u'GW-2016', u'Lapatinib [INN:BAN]', u'GW 282974X', u'HSDB 8209', u'1xkk', u'Lapatinib, Tykerb, GW572016', u'N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine', u'N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine', u'Lapatinib Ditosylate/', u'PubChem7650', u'nchembio866-comp20', u'Kinome_3684', u'Kinome_3685', u'AC1L4LL4', u'SCHEMBL8100', u'BDBM5445', u'cid_208908', u'GTPL5692', u'QCR-63', u'DTXSID7046675', u'AOB5254', u'EX-A402', u'SYN1052', u'BCFGMOOMADDAQU-UHFFFAOYSA-N', u'BCPP000188', u'BCPP000189', u'HMS2089H10', u'HMS3244N06', u'HMS3244N10', u'HMS3244N14', u'Tykerb (TN) (Glaxo Smith Kline)', u'AMX10154', u'BCP01874', u'KS-00000GH2', u'ZINC1550477', u'Tox21_112505', u'ABP000866', u'ABP000872', u'AKOS005145766', u'Tox21_112505_1', u'AC-1314', u'AN-5195', u'AN-5300', u'API0003126', u'BCP9000837', u'BCP9000838', u'CM14421', u'DB01259', u'NSC-745750', u'RL02729', u'SB16918', u'NCGC00167507-02', u'NCGC00167507-03', u'NCGC00167507-04', u'NCGC00167507-09', u'4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline', u'913989-15-8', u'AK-46487', u'AS-14065'], 4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, 4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline, Gd 2016, Gsk 572016, Gw 572016, Gw 572016X, Lapatinib base, N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-(methanesulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine, N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine, N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine, N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine, N-[4-(3-Fluorobenzyloxy)-3-chlorophenyl]-6-[5-[[2-(methylsulfonyl)ethylamino]methyl]furan-2-yl]quinazolin-4-amine, N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine, Tycerb, Tyverb
• CAS: 231277-92-2
• Marca: Indagoo

Propiedades químicas

• Peso molecular: 581.0575
• Fórmula: C₂₉H₂₆ClFN₄O₄S
• Pureza: 99%
• Color/Forma: Solid
• InChI: InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)
• Clave InChI: BCFGMOOMADDAQU-UHFFFAOYSA-N